2022年12月最新中科院JCR期刊分区表数据(升级版)已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。 ![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | LEUKEMIA RESEARCH LEUKEMIA RES LetPub评分 5.4
50人评分
我要评分
声誉 6.4 影响力 3.9 速度 9.1 | |||||||||||||||||||||||||
期刊ISSN | 0145-2126 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
E-ISSN | 1873-5835 | |||||||||||||||||||||||||
2021-2022最新影响因子 (数据来源于搜索引擎) | 注册或登录后,查看影响因子和历年趋势图 | |||||||||||||||||||||||||
2021-2022自引率 | 2.20%注册或登录后,查看自引率趋势图 | |||||||||||||||||||||||||
h-index | 81 | |||||||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||||||
期刊简介 | Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases. | |||||||||||||||||||||||||
期刊官方网站 | http://www.journals.elsevier.com/leukemia-research/ | |||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/LR | |||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||
通讯方式 | PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB | |||||||||||||||||||||||||
出版商 | Elsevier Ltd | |||||||||||||||||||||||||
涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||
出版年份 | 1977 | |||||||||||||||||||||||||
年文章数 | 126注册或登录后,查看年文章数趋势图 | |||||||||||||||||||||||||
Gold OA文章占比 | 8.72% | |||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 93.65% | |||||||||||||||||||||||||
WOS期刊SCI分区 ( 2021-2022年最新版) | WOS分区等级:3区
| |||||||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2021年12月发布的2021版:不在预警名单中 2021年01月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2022年12月最新升级版) | 注册或登录后,查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月基础版) |
| |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月升级版) |
| |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年12月旧的升级版) |
| |||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0145-2126%5BISSN%5D | |||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 一般,3-6周 来源Elsevier官网: 平均7.7周 | |||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
注册或登录后,查看自引率趋势图 |
注册或登录后,查看中科院SCI期刊分区趋势图 |
注册或登录后,查看年文章数趋势图 |
中国学者近期发表的论文 | |
1. | Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1 Author: Li Li, Yixin Cui, Jinyan Shen, Hannah Dobson, Gongqin Sun Journal: LEUKEMIA RESEARCH, 2019, Vol.78, 12-20, DOI:10.1016/j.leukres.2019.01.006 DOI |
2. | A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia Author: Hong Luo, Suo Zhang, Ke Li, Xing-Hua Chen, Yan-Chun Li, Yuan Sun, Li-Feng Liu, Hui-Yang Yu, Hong-Hu Zhu Journal: LEUKEMIA RESEARCH, 2018, Vol.77, 14-16, DOI:10.1016/j.leukres.2018.12.009 DOI |
3. | LMO2 functional and transcriptional regulatory profiles in hematopoietic cells Author: Chao Wu, Mei Yuan, Yang Gao, Wei Sun Journal: LEUKEMIA RESEARCH, 2018, Vol.75, 11-14, DOI:10.1016/j.leukres.2018.10.013 DOI |
4. | MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression Author: Chen Huan, Lou Jin, Wang Heng, An Na, Pan Yuming, Du Xin, Zhang Qiaoxia Journal: LEUKEMIA RESEARCH, 2018, Vol.75, 1-6, DOI:10.1016/j.leukres.2018.10.012 DOI |
5. | Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI. Author: Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Journal: Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. PubMed |
6. | The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia. Author: Chen H, Wang N, Yang G, Guo Y, Shen Y, Wang X, Zhang P, Xu Y. Journal: Leuk Res. 2016 Mar;42:28-36. doi: 10.1016/j.leukres.2016.01.013. Epub 2016 Jan 28. PubMed |
7. | Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study. Author: Duan MH, Han X, Li J, Zhang W, Zhu TN, Han B, Zhuang JL, Wang SJ, Cao XX, Cai HC, Chen M, Yang C, Zhou DB. Journal: Leuk Res. 2016 Mar;42:43-6. doi: 10.1016/j.leukres.2016.01.012. Epub 2016 Jan 28. PubMed |
8. | CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients. Author: Li XM, Zhang LP, Wang YZ, Lu AD, Chang Y, Zhu HH, Qin YZ, Lai YY, Kong Y, Huang XJ, Liu YR. Journal: Leuk Res. 2016 Apr;43:33-8. doi: 10.1016/j.leukres.2015.12.015. Epub 2016 Jan 4. PubMed |
9. | SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis. Author: Zhu Y, Li X, Chang C, Xu F, He Q, Guo J, Tao Y, Liu Y, Liu L, Shi W. Journal: Leuk Res. 2016 May;44:8-16. doi: 10.1016/j.leukres.2016.02.011. Epub 2016 Feb 27. PubMed |
10. | Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells. Author: Geng S, Yao H, Weng J, Tong J, Huang X, Wu P, Deng C, Li M, Lu Z, Du X. Journal: Leuk Res. 2016 May;44:17-24. doi: 10.1016/j.leukres.2016.02.002. Epub 2016 Feb 16. PubMed |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共3条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451